Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study
Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study(452 views) Pedone C, Di Pasquale G, Greco C, Gonzini L, Maggioni AP, Pavesi PC, Sabini A, Boccanelli A; In-Acs Outcome Investigators
Acute Cardiac Care (ISSN: 1748-295x, 1748-2941), 2009; 11(4): 222-228.
Maggiore Hospital, Dept. of Cardiology, Bologna, Italy.
San Giovanni Hospital, Dept. of Cardiology, Roma, Italy
ANMCO Research Center, Firenze, Italy
San Donato Hospital, Dept. of Cardiology, Arezzo, Italy
References: Fox, K.A.A., Steg, P.G., Eagle, K.A., Goodman, S.G., Anderson, F.A., Granger, C.B., Decline rates of death and heart failure in acute coronary syndromes, 1999-2006 (2007) JAMA, 297, pp. 1892-190
Antman, E.M., Hand, M., Armstrong, P.W., Bates, E.R., Green, L.A., Halasyamani, L.K., 2007 focused update of the ACC/ AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction (2008) J Am Coll Cardiol, 51, pp. 210-247. , A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction)
Van De Werf, F., Bax, J.J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., Falk, V., Management of acute myocardial infarction in patients presenting with ST-segment elevation (2008) Eur Heart J, 29, pp. 2909-2945. , The task force on the management of acute myocardial infarction of the European Society of Cardiology
Chen, Z.M., Jiang, L.X., Chen, Y.P., Xie, J.X., Pan, H.C., Peto, R., Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: Randomised placebo-controlled trial (2005) Lancet, 366, pp. 1607-1621. , COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group)
Sabatine, M.S., Cannon, C.P., Gibson, G.M., Lopez-Sendon, J.L., Montalescot, G., Theroux, P., Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation (2005) N Engl J Med, 352, pp. 1179-1189
Danchin, N., Grenier, O., Ferrières, J., Cantet, C., Cambou, J.P., Use of secondary preventive drugs in patients with acute coronay syndromes treated medically or with coronary angioplasty: Results from the nationwide French Prevenir survey (2002) Heart, 88, pp. 159-162
Steg, P.G., Iung, B., Feldman, L.J., Cokkinos, D., Deckers, J., Fox, K.A.A., Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes (2002) Heart, 88, pp. 20-24. , For the Enact Investigators
Hasdai, D., Behar, S., Wallentin, L., Danchin, N., Gitt, A.K., Boersma, E., A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin
The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS) (2002) Eur Heart J, 23, pp. 1190-1201
Yan, A.T., Yan, R.T., Tan, M., Huynh, T., Soghrati, K., Brunner, L.J., Optimal medical therapy at discharge in patients with acute coronary syndromes: Temporal changes, characteristics, and 1-year outcome (2007) Am Heart J, 154, pp. 1108-1115. , Canadian ACS Registries Investigators
Granger, C.B., Steg, P.G., Peterson, E., López-Sendón, J., Van De Werf, F., Kline-Rogers, E., Medication performance measures and mortality following acute coronary syndromes (2005) Am J Med, 118, pp. 858-866. , GRACE Investigators
Tricoci, P., Peterson, E.D., Roe, M.T., Patterns of guideline adherence and care delivery for patients with unstable angina and non-ST-segment elevation myocardial infarction (from the CRUSADE Quality improvement initiative) (2006) Am J Cardiol, 98 (SUPPL.), pp. 30Q-50Q
Di Chiara, A., Fresco, C., Savonitto, S., Greco, C., Lucci, D., Gonzini, L., Epidemiology of non-ST elevation acute coronary syndromes in the Italian cardiology network: The BLITZ-2 study (2006) Eur Heart J, 27, pp. 393-405. , On behalf of the BLITZ-2 Investigators
Heras, M., Bueno, H., Bardaj́, A., Fernández-Ortiz, A., Mart́, H., Marrugat, J., Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: Insights from the DESCARTES Registry (2006) Heart, 92, pp. 1571-1576. , DESCARTES Investigators
Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study
PURPOSE: To analyse discharge prescription of recommended treatments in patients with ST-segment elevation myocardial infarction (STEMI) according to reperfusion strategies.; METHODS: IN-ACS (Italian Network on Acute Coronary Syndromes) Outcome, an observational, multicenter study, enrolled 6045 ACS patients admitted within 48 h. In the present study we compared the discharge prescription rates of secondary prevention drugs among the 2144 patients with STEMI (72.5% men, age 65+/-13 years) who received primary percutaneous coronary intervention (pPCI) 1044 (48.7%) or thrombolytic therapy (TT) 575 (26.8%) or no reperfusion treatment (NR) 525 (24.5%).; RESULTS: Despite the higher risk profile, NR patients respect to pPCI and TT were less frequently receiving antiplatelet (93.0% versus 99.7% versus 96.4%), dual antiplatelet (57.9% versus 93.9% versus 62.8%), beta-blockers (71.2% versus 82.9 versus 75.0%) and statins (68.4% versus 78.6% versus 76.9%) (P
Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study
Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study